Megan Barnes' grief over father's death from pancreatic cancer led to new drug subsidy

By Monica Heary
October 1 2014 - 8:16pm
Victory: Megan Barnes's campaign paid off. Picture: Jane Dyson

ALTHOUGH it has come too late to help her father, Megan Barnes is elated at the news that the pancreatic cancer drug Abraxane will receive a Pharmaceutical Benefits Scheme (PBS) listing that will mean it costs a concessional patient just $6 a script.

Advertisement

Ad

Advertisement

Ad